Identification of novel prognostic model based on homologous recombination deficiency associated lncRNAs in lung adenocarcinoma

Xi Liu; Tao Wang; Zhipeng Ren; Changjiang Feng; Xiaodong Tian

doi:10.1016/j.heliyon.2023.e14811

ScienceGate Book Chapters

JOURNAL ARTICLE

Identification of novel prognostic model based on homologous recombination deficiency associated lncRNAs in lung adenocarcinoma

Xi Liu Tao Wang Zhipeng Ren Changjiang Feng Xiaodong Tian

Year: 2023 Journal: Heliyon Vol: 9 (4)Pages: e14811-e14811 Publisher: Elsevier BV

DOI: 10.1016/j.heliyon.2023.e14811

Get Full-Text PDF Get Analytical Report

Keywords:

Nomogram Immunotherapy Oncology Proportional hazards model Lung cancer Adenocarcinoma Survival analysis Immune system Medicine Internal medicine Computational biology Biology Cancer Immunology

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.03

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Cancer-related molecular mechanisms research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

RNA modifications and cancer

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Viral-associated cancers and disorders

Health Sciences → Medicine → Oncology

Identification of novel prognostic model based on homologous recombination deficiency associated lncRNAs in lung adenocarcinoma

Metrics

Topics

Related Documents

Development of a Novel Prognostic Model for Lung Adenocarcinoma Utilizing Pyroptosis‐Associated LncRNAs

Identification of immune-associated lncRNAs as a prognostic marker for lung adenocarcinoma

A Risk Model Developed based on Homologous Recombination Deficiency Genes for Evaluating the Drug Sensitivity and Prognostic Prediction of Lung Adenocarcinoma

Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma

Identification of prognostic indicator based on hypoxia-related lncRNAs analysis in lung adenocarcinoma